LuciErda 3 mg Tablet

Brand Name:   LuciErda
Molecule:   Erdafitinib
Strength:   3 mg
Quantity:   28 Tablets
Form:   Tablet
Packaging Type:   Bottle
Manufacturer/Marketed By:   Lucius Pharma
Country of Origin:   Laos
No similar products found.

Description

Active Ingredient: Each film-coated tablet contains Erdafitinib 4 mg. Indications: LuciErda is a kinase inhibitor used for the treatment of locally advanced or metastatic urothelial carcinoma (mUC) in adult patients with: Susceptible FGFR3 or FGFR2 genetic alterations, and Disease progression during or after at least one prior platinum-based chemotherapy (including within 12 months of neoadjuvant/adjuvant platinum therapy). Dosage & Administration: Confirm FGFR alterations via testing before starting treatment. The recommended starting dose is 8 mg once daily, taken orally. May be increased to 9 mg daily if predefined criteria are met. Swallow tablets whole, with or without food.

Related Products

Related Posts:

No matching posts found.

0 reviews
0
0
0
0
0

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.